Martinsried, Germany

Stella Grosso

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Baxter Healthcare Sa, Baxter International Inc., Leukocare Ag. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stella Grosso: Innovator in Fibrin Sealant Technology

Introduction

Stella Grosso is a prominent inventor based in Martinsried, Germany. She has made significant contributions to the field of medical technology, particularly in the development of fibrin sealants. Her innovative work has led to the creation of a patented solution that enhances wound treatment.

Latest Patents

Stella Grosso holds a patent for "Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit." This patent discloses a fibrinogen solution that contains fibrinogen at a concentration of at least 40 mg/ml, along with factor XIII, pharmaceutically acceptable additives, and water. The dynamic viscosity of this solution, measured at 20° C., increases by at most 35% after being stored at 20° C. for 30 days. Additionally, the thrombin solution comprises thrombin, pharmaceutically acceptable additives, and water, with thrombin activity decreasing by at most 15% after storage at 25° C. for 14 days. The patent also includes a fibrin sealant kit that contains both the fibrinogen and thrombin solutions, along with methods for preparing a fibrin sealant and treating wounds.

Career Highlights

Throughout her career, Stella has worked with notable companies such as Baxter International Inc. and Leukocare AG. Her experience in these organizations has allowed her to refine her expertise in medical solutions and contribute to advancements in healthcare technology.

Collaborations

Stella has collaborated with esteemed colleagues, including Heinz Gulle and Rahul Kumar Singh. These partnerships have further enriched her work and expanded the impact of her innovations in the medical field.

Conclusion

Stella Grosso's contributions to fibrin sealant technology exemplify her dedication to improving medical treatments. Her innovative solutions and collaborations have positioned her as a key figure in the advancement of healthcare technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…